Efficacy and Safety of Satralizumab from Two Phase 3 Trials in Neuromyelitis Optica Spectrum Disorder (Video)

Update Item Information
Identifier 20200309_nanos_sciplatform1_03
Title Efficacy and Safety of Satralizumab from Two Phase 3 Trials in Neuromyelitis Optica Spectrum Disorder (Video)
Creator Benjamin Frishberg; Jerome de Seze; Brian Weinshenker; Yusuke Terada; Yuichi Kawata; Athos Gianella-Borradori; H. Christian von Büdingen; Gaelle Klingelschmitt; Anthony Traboulsee; Takashi Yamamura
Affiliation (BF) The Neurology Center of Southern California, Carlsbad, California; (JS) Department of Neurology, Hôpital de Hautepierre, Paris, France; (BW) Mayo Clinic, Rochester, Minnesota; (YT) (YK) Chugai Pharmaceutical Co., Ltd, Tokyo, Japan; (AG) Chugai Pharma USA, Inc. At the time of the study, Berkeley Heights, New Jersey, Switzerland; (HC) F. Hoffmann-La Roche Ltd,, Basel, Switzerland; (AT) The University of British Columbia, Vancouver, Canada; (TY) National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
Subject Optic Neuritis, Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid), Optic Nerve Trauma and Treatment, Non-Organic Visual Disorders, Miscellaneous
Description Satralizumab is a humanized recycling monoclonal antibody that binds to the interleukin-6 (IL-6) receptor; IL-6 has been implicated in the pathophysiology of neuromyelitis optica spectrum disorder (NMOSD). Satralizumab was evaluated in patients with NMOSD in two Phase 3 studies: SAkuraSky (NCT02028884) and SAkuraStar (NCT02073279). In this analysis, we assessed the efficacy and safety of satralizumab in the individual study and pooled patient populations, including the subgroup of patients who were seropositive foraquaporin-4 immunoglobulin G (AQP4-IgG).
Date 2020-03
Language eng
Format video/mp4
Type Image/MovingImage
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: Scientific Platform Session I
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6qk2sc3
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 1541918
Reference URL https://collections.lib.utah.edu/ark:/87278/s6qk2sc3
Back to Search Results